Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TipRanks15:20 · Ratings

Fulcrum Therapeutics Slides As Insider Purchases Lose Another US$362k

Simply Wall StNov 16 21:18

Oppenheimer Maintains Fulcrum Therapeutics(FULC.US) With Buy Rating, Maintains Target Price $14

Futu NewsNov 14 21:35 · Ratings

RBC Capital Maintains Fulcrum Therapeutics(FULC.US) With Hold Rating, Maintains Target Price $4

Futu NewsNov 14 20:31 · Ratings

Fulcrum Therapeutics Analyst Ratings

BenzingaNov 14 19:51 · Ratings

H.C. Wainwright Maintains Fulcrum Therapeutics(FULC.US) With Hold Rating, Maintains Target Price $4

Futu NewsNov 14 19:31 · Ratings